Top Markets
Coin of the day
Johnson & Johnson Johnson & Johnson

Johnson & Johnson

JNJ
Rang in aandelen #18
Johnson & Johnson, together with its subsidiaries, researches and develops,... Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. It also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment offers products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS and COVID-19 infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment provides electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. The company was founded in 1886 and is based in New Brunswick, New Jersey.
Aandeelprijs
$240.45
Marktkapitalisatie
$579.46B
Verandering (1 dag)
0.51%
Verandering (1 jaar)
46.88%
Land
US
Handel Johnson & Johnson (JNJ)

Categorie

Operationele marge voor Johnson & Johnson (JNJ)
Operationele marge op March 2026 TTM: 27.17%
Volgens de meest recente financiële rapporten en aandelenkoers van Johnson & Johnson is de huidige operationele marge (TTM) 27.17%. Eind 2024 had het bedrijf een operationele marge van 24.94%.
Geschiedenis van de operationele marge van Johnson & Johnson van 2000 tot 2026
Operationele marge aan het einde van elk jaar
Jaar Operationele Marge Wijzigen
2026 (TTM) 27.17% 0.00%
2025 27.17% 8.94%
2024 24.94% -9.28%
2023 27.49% 3.35%
2022 26.60% 11.34%
2021 23.89% -6.50%
2019 25.55% -1.58%
2018 25.96% 5.02%
2017 24.72% -5.29%
2016 26.10% -8.23%
2014 28.44% 7.00%
2013 26.58% 4.89%
2012 25.34% -5.59%
2011 26.84% -0.30%
2010 26.92% 6.15%
2008 25.36% 1.85%
2007 24.90% -3.15%
2006 25.71% -1.49%
2005 26.10% 0.50%
2003 25.97% -2.59%
2002 26.66% 9.26%
2001 24.40% 7.58%
2000 22.68% 0.00%
Operationele marge van vergelijkbare bedrijven of concurrenten
Bedrijf Operationele Marge Verschil in operationele marge Land
45.56% -98.32%
US
26.72% -99.02%
US
31.24% -98.85%
CH
23.28% -99.14%
GB
41.19% -98.48%
US
Wat is de Operationele marge van een bedrijf?
De Operationele marge is een belangrijke indicator om de winstgevendheid van een bedrijf te beoordelen. Hogere operationele marges zijn over het algemeen beter omdat ze aangeven dat een bedrijf zijn producten of diensten veel duurder kan verkopen dan de productiekosten. De Operationele marge wordt berekend door de winst van een bedrijf te delen door de omzet.